Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000730340 | SCV000858069 | uncertain significance | not provided | 2017-11-08 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001478361 | SCV001682631 | likely benign | Wolman disease | 2023-07-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002422627 | SCV002727628 | likely benign | Cardiovascular phenotype | 2019-09-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |